# UL earnings call intelligence LOPJLB CallCard / temporal rollup · freemium · [stock page](https://www.lopjlb.com/stock/UL) · [Earnings tab](https://www.lopjlb.com/stock/UL?tab=earnings) Updated: 2026-07-28T05:42:23 Quarters analyzed: 8 ## Cross-quarter narrative Across eight earnings calls Unilever’s core story shifted from early‑year optimism about sales momentum and a on‑track Growth Action Plan to a more nuanced picture where growth remains solid but is increasingly tempered by regional headwinds and execution delays. Underlying sales grew between 4.1% and 4.5% each quarter, while gross margins crept up to a record 45%, driven by commodity deflation early on and later by productivity savings. The Ice Cream de‑merger, a strategic pillar from Q1 2024, moved from on‑track to at‑risk in 2025 Q3 due to a U.S. regulatory pause before finally delivering in 2025 Q4. Productivity programmes stayed on schedule, delivering cost cuts and role reductions. Market‑share concerns in home‑care and emerging‑market pricing pressure persisted, especially in Brazil, Indonesia and China, where sales softness prompted delayed interventions. Currency volatility and macro‑economic uncertainty remained constant back‑drops, eroding turnover despite higher pricing. Brand investment intensified around Power Brands and new wellbeing offerings, while a series of acquisitions (Minimalist, Magnum‑related assets, Dr. Squatch, Wild) and disposals (Russia, water business) progressed as planned. Overall, the narrative evolved from growth confidence to a balanced focus on margin protection, regional recovery, and the final execution of the Ice Cream split. ## Latest CallCard · Q4 Unilever posted solid 2025 results, highlighted portfolio simplification and growth in emerging markets, and reaffirmed a 4‑6% sales outlook for 2026 with focus on volume, mix and margin expansion. **Guidance:** maintained — Guidance stays at the bottom of the 4‑6% sales growth range, with confidence in volume‑led growth and modest margin improvement. **Tone:** mgmt 0.6 · Q&A pressure 0.4 · divergence 0.3 Prepared remarks emphasized a solid year, confidence in the transformed portfolio and a simpler, sharper business. ### Demand visibility Emerging markets are stepping up while some Latin America markets remain flat. India shows stronger brand equity and share gains; Indonesia reset has low distributor stock and brand relaunches; China is improving in H2 2025; Brazil and Latin America volumes are flat or modest. ### Margins / costs Margin expansion driven by high gross margin and productivity savings. Gross margin now 46.9%; productivity program has delivered €670 m of savings with a remaining €130 m to meet the €800 m target; commodity inflation is limited to palm, canola oil and surfactants. ### Capital allocation 16% of revenue invested in brands; 70‑30 dividend‑buyback split; capex ~3% of turnover. Returned €6 bn to shareholders (€4.5 bn dividends, €1.5 bn buybacks). Capex 3% of turnover with 55‑60% earmarked for productivity and margin‑enhancing projects. ### Milestones - **Ice Cream demerger** [delivered]: Completed and now a separate business, increasing focus on core portfolio. - **Acquisition of Minimalist** [delivered]: Strengthened Beauty & Wellbeing premium segment. - **Acquisition of Wild** [delivered]: Added premium Personal Care capabilities. - **Acquisition of Dr. Squatch** [delivered]: Enhanced US and India premium exposure. - **Disposal of Russia and China water business** [delivered]: Reduced non‑core assets, improving portfolio focus. - **Disposal of Conimex, The Vegetarian Butcher, Kate Somerville** [delivered]: Further portfolio simplification. - **Wonder Wash launch** [delivered]: Now in >30 markets, demonstrating rapid innovation rollout. - **Indonesia market reset** [on_track]: Low distributor stock and relaunch of 8 top brands improving sales run‑rates. ### Fears / risks - **Emerging market volatility**: Growth in emerging markets depends on macro conditions; Latin America remains flat. - **Latin America flat growth**: Volume growth near 0% with price pressure; Brazil and Mexico face macro challenges. - **Commodity inflation**: Palm oil, canola oil and surfactants see year‑on‑year price pressure. - **US Wellbeing price pressure**: Wellbeing volumes slowed in Q4; higher customer acquisition costs for Nutrafol. - **Channel price conflicts Brazil**: Past pricing conflicts required corrective actions; risk of recurrence. - **Currency headwinds**: FX reduced turnover by 5.9% in 2025, affecting profitability. - **European market slowdown**: Foods segment soft in Netherlands and Germany, weighing on overall Europe growth. - **Retail pricing pressure**: Increased promotional intensity in Foods could compress margins. ### Key quotes > “We have delivered a solid year, fully in line with our commitments despite challenging conditions.” > “Underlying sales growth was 3.5%, with volumes at 1.5% and price at 2%.” > “We enter 2026 as a simpler, more focused business with stronger brands and competitive level of investment.” ## Quarter one-liners - **2025 Q4:** Unilever posted solid 2025 results, highlighted portfolio simplification and growth in emerging markets, and reaffirmed a 4‑6% sales outlook for 2026 with focus on volume, mix and margin expansion. - **2025 Q3:** Unilever posted 4% underlying sales growth, strong North America performance and premium brand momentum, while noting Latin America softness and a delayed Ice Cream demerger due to a U.S. shutdown; outlook unchanged. - **2025 Q2:** Unilever posted 3.4% first‑half underlying sales growth, balanced volume and price, reaffirmed 3‑5% FY growth and 18.5% H2 margin target, and highlighted an on‑track Ice Cream demerger and strong brand momentum. - **2025 Q1:** Unilever’s new CEO stresses strong fundamentals, a robust innovation pipeline and a €550 m productivity drive while reaffirming 3‑5% FY25 sales growth amid macro‑economic and currency uncertainty. - **2024 Q4:** Unilever posted 4.2% sales growth, 45% gross margin and €5.8bn returns while advancing its Growth Action Plan, productivity cuts and Ice Cream de‑merger, but flags slower Q1, commodity‑price inflation and China/Indonesia recovery risks. - **2024 Q3:** Unilever posted 4.5% underlying sales growth in Q3, driven by volume gains and Power Brands, while flagging a tough turnaround in Indonesia and ongoing restructuring in Europe. - **2024 Q2:** Unilever posted solid H1 2024 results with 4.1% sales growth, 420bps margin expansion and €700m brand spend, but flagged Ice Cream weakness, commodity cost headwinds and regional challenges while keeping FY guidance unchanged. - **2024 Q1:** Unilever Q1 2024 showed 4.4% underlying sales growth, strong Power Brands performance and progress on its GAP, while flagging market‑share concerns and a planned Ice Cream split by end‑2025. ## Theme arcs - **Underlying sales growth** (stable): Quarterly growth stayed in the 4‑5% range despite regional dips - **Gross margin expansion** (improving): Margins rose from 45.7% to a new 45% base, aided by cost savings and commodity trends - **Ice Cream de‑merger execution** (deteriorating): Initially on‑track, later delayed by regulatory issues before delivery - **Productivity programme** (improving): Consistently on‑track, delivering savings and role reductions - **Market‑share pressure in emerging markets** (deteriorating): Indonesia and China softness persisted, prompting delayed interventions - **Currency and macro volatility** (stable): Continuous headwind across all calls - **Brand investment in Power Brands** (stable): Spend remained ~15% of turnover, focused on high‑growth categories - **Acquisition and disposal activity** (improving): Multiple acquisitions delivered and disposals completed as scheduled ## Fear persistence - **Market‑share concerns** [resolved]: Raised in Q1 2024, not referenced in later calls - **Pricing pressure / commodity inflation** [recurring]: Repeated mentions of price cuts, inflation risk, and margin impact - **Currency volatility** [recurring]: Consistent adverse impact on turnover and margins - **Indonesia challenges** [recurring]: Persistent sales weakness and delayed intervention - **China slowdown** [recurring]: Ongoing soft demand and flat volumes - **Regulatory delay (U.S. shutdown)** [new]: Appeared only in 2025 Q3 affecting Ice Cream demerger - **Macro‑economic uncertainty** [recurring]: Repeated references to global economic volatility - **Competitive pressure** [recurring]: Higher marketing spend and discounting in key markets ## Guidance path 2024 Q1:maintained → 2024 Q2:maintained → 2024 Q3:maintained → 2024 Q4:maintained → 2025 Q1:maintained → 2025 Q2:maintained → 2025 Q3:maintained → 2025 Q4:maintained --- Research context only. Not personalized investment advice. API: `GET /bff/api/bigfive/earnings-intel/UL`